Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single-cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering. 

Biotechnology

Education

Immunitas Therapeutics

Amanda Wagner

James Wooldridge

Ming Tang

Char Gross

Xianzhe Wang

Shruti Malu

Lynette Herscha

The Scientific Research team at Immunitas Therapeutics drives the discovery and development of novel immuno-oncology therapies. Leveraging a single-cell genomics platform, the team focuses on rapid target identification and validation, alongside antibody discovery and engineering. This multidisciplinary group collaborates to translate scientific findings into clinical applications, aiming to develop breakthrough treatments for cancer.

Scientific Research

Scientific and Clinical Advisors

Leadership Team

Scientific Research

About

Team members

Other teams at Immunitas Therapeutics

Scientific and Clinical Advisors

Leadership Team